Phase 3 Brain Cancer Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Brain CancerGlioblastomaGBM+4 more
Northwell Health432 enrolled1 locationNCT05271240
Not Yet Recruiting
Phase 3
The CONCISE trial: Condensed Chemoradiotherapy Schedule for Glioblastoma
Brain CancerGlioblastoma
The Walter and Eliza Hall Institute of Medical Research (WEHI)330 enrolled1 locationACTRN12626000036314
Completed
Phase 3
Phase III Trial of Extended Temozolomide in Newly Diagnosed Glioblastoma
Brain CancerGlioblastoma
The Walter and Eliza Hall Institute of Medical Research315 enrolled15 locationsACTRN12618001944224